These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 12545287)
21. Photodynamic therapy with verteporfin for choroidal neovascularization due to age-related macular degeneration and other causes: a New Zealand outcomes study. Sharp DM; Lai S; Markey CM Clin Exp Ophthalmol; 2007; 35(1):24-31. PubMed ID: 17300567 [TBL] [Abstract][Full Text] [Related]
22. Intravitreal injection of bevacizumab combined with verteporfin photodynamic therapy for choroidal neovascularization in age-related macular degeneration. Smith BT; Dhalla MS; Shah GK; Blinder KJ; Ryan EH; Mittra RA Retina; 2008 May; 28(5):675-81. PubMed ID: 18463509 [TBL] [Abstract][Full Text] [Related]
23. Periocular triamcinolone and photodynamic therapy for subfoveal choroidal neovascularization in age-related macular degeneration. ; Gilson MM; Bressler NM; Jabs DA; Solomon SD; Thorne JE; Wilson DJ Ophthalmology; 2007 Sep; 114(9):1713-21. PubMed ID: 17822977 [TBL] [Abstract][Full Text] [Related]
24. Photodynamic therapy for age-related macular degeneration. Jin C; Ge J; Zhou S; Chen H; Zhong X; Jiang R; Chen L; Chen L Yan Ke Xue Bao; 2004 Sep; 20(3):158-62. PubMed ID: 15499723 [TBL] [Abstract][Full Text] [Related]
25. Photodynamic therapy with verteporfin in patients with age-related macular degeneration and juxtafoveal choroidal neovascularization. Frennesson CI Acta Ophthalmol Scand; 2004 Dec; 82(6):651-5. PubMed ID: 15606459 [TBL] [Abstract][Full Text] [Related]
26. Verteporfin and intravitreal triamcinolone acetonide combination therapy for occult choroidal neovascularization in age-related macular degeneration. Augustin AJ; Schmidt-Erfurth U Am J Ophthalmol; 2006 Apr; 141(4):638-45. PubMed ID: 16564797 [TBL] [Abstract][Full Text] [Related]